CHM chimeric therapeutics limited

Ann: Positive pre-IND meeting with FDA for Phase 1 CAR T study, page-9

  1. 3,592 Posts.
    lightbulb Created with Sketch. 788
    CHM have a long long long road ahead of themselves and the market knows this..

    CHM will need to do many CRs b4 any revenue if at all is realised..and the market knows this..

    The market clearly knows there is no rush to buy onto this company just yet..all my opinion of course

    again my opinion the sp will get worse b4 it gets better..long term view may not matter..and an emphasis on the word MAY is one of the reasons I believe the sp will get worse b4 it gets better

    keep safe and as always

    dyor..just my opinion and never advice
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.